Your browser doesn't support javascript.
loading
Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development.
Hicks, Dustin; Baehr, Carly; Silva-Ortiz, Pedro; Khaimraj, Aaron; Luengas, Diego; Hamid, Fatima A; Pravetoni, Marco.
Afiliación
  • Hicks D; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Baehr C; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Silva-Ortiz P; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Khaimraj A; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Luengas D; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Hamid FA; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Pravetoni M; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
Hum Vaccin Immunother ; 18(6): 2122507, 2022 Nov 30.
Article en En | MEDLINE | ID: mdl-36194773
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fentanilo / Anticuerpos Monoclonales Humanizados / Antagonistas de Narcóticos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fentanilo / Anticuerpos Monoclonales Humanizados / Antagonistas de Narcóticos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos